All are obstructive lung disease except
**Obstructive Lung Disease**
**Core Concept**
Obstructive lung disease is characterized by airway obstruction, which results in difficulty exhaling air from the lungs. This condition is often associated with conditions such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis.
**Why the Correct Answer is Right**
The correct answer is an obstructive lung disease. Obstructive lung diseases are typically caused by inflammation, hypersecretion of mucus, and airway remodeling, leading to airway narrowing and increased resistance to airflow. This results in symptoms such as wheezing, shortness of breath, and coughing.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is an example of restrictive lung disease, which is characterized by a reduced lung volume and a decrease in lung compliance. Restrictive lung diseases include conditions such as pulmonary fibrosis, sarcoidosis, and pneumoconiosis.
**Option B:** This option is an example of a mixed obstructive and restrictive pattern, which can be seen in conditions such as pulmonary sarcoidosis or pulmonary sarcoidosis with pulmonary fibrosis.
**Option C:** This option is an example of a vasculitic lung disease, which is characterized by inflammation of the blood vessels in the lungs. Vasculitic lung diseases include conditions such as Wegener's granulomatosis and Churg-Strauss syndrome.
**Option D:** This option is an example of a pleural disease, which is characterized by inflammation or infection of the pleura, the membrane surrounding the lungs. Pleural diseases include conditions such as pleurisy and pleural effusion.
**Clinical Pearl / High-Yield Fact**
When differentiating between obstructive and restrictive lung diseases, it is essential to assess lung volumes and capacities, particularly the forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC). A ratio of FEV1 to FVC of less than 0.7 is characteristic of obstructive lung disease.
**Correct Answer: A. Restrictive lung disease.**